Method for augmenting a decreased level of reduced glutathione in the lung
US5989521A · kind A · utility
15Cited by
2References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 31, 1991 |
| Grant date | Nov 23, 1999 |
| Priority date | — |
| Expiry date | Dec 31, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in general, to a method for augmenting reduced glutathione level in the lungs of patients. In particular, the present invention relates to a method for augmenting reduced glutathione level in the lungs of patients with cystic fibrosis (CF), acquired immunodeficiency syndrome (AIDS), or idiopathic pulmonary fibrosis (IPF).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.